CYBN subsidiary Adelia Therapeutics has reached earn-out milestones. Adelia’s earn-out milestones contributed to positive preclinical results with multiple proprietary psychedelic molecules. Cybin’s development of these compounds differentiates it from companies focused on naturally occurring psychedelic compounds. Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced that earn-out milestones have […]

PlantX Life recently launched as a seller on both Walmart Canada Marketplace and Hudson’s Bay Marketplace The launches appear to be leveraging the changes and trends brought about by the COVID-19 pandemic In addition, the agreements are part of PlantX’s growth strategy The company will offer thousands of its products on both platforms As the […]

GTVH, HyFrontier Technologies working together to offer a patent-pending hydrogen and oxygen delivery system for agriculture. Company has seen recent developments that could significantly benefit the entire agricultural industry. Duplicating enhanced-growth thunderstorms cause can reduce need for crop rotations, helping millions of people avoid starvation. A little more than a month after announcing its formal […]

The program’s initial focus is to support those at risk or already diagnosed with diabetes or cardiovascular disease, offering better health management and quality of life In the United States, approximately 88 million adults live with prediabetes, and as many as 84% do not know they have it. It is estimated that by 2030, 13.6 […]

Industry experts share expertise, insight in next DealMaker webinar. Successful Reg A+ offerings tell their stories across multiple mediums. DealMaker is building a reputation for its ability to offer services that support companies across a wide array of needs. With its mission of delivering speed, innovation and efficiency to global capital markets in mind, DealMaker […]

San Diego-based Tryp Therapeutics is developing new drug candidates with the aim of treating medical conditions that currently have limited effective therapy Tryp has solidified an agreement with the University of Michigan’s Chronic Pain & Fatigue Research Center and the Center for Consciousness Science to test synthetic psychedelic drug candidate TRP-8803 to advance its use […]

Drug delivery platform developer Lexaria Bioscience recently received its 20th patent — granted in Japan for beverages with lipophilic active agents The active agents include non-psychoactive cannabinoids and over-the-counter NSAIDS such as ibuprofen and aspirin that target pain and inflammation Lexaria’s DehydraTECH platform transforms drugs into a powder or liquid form that maintains the drug’s […]

Scientific evidence is mounting that SARS-CoV-2 can cause neurological damage in patients hospitalized with the infection. A recent study that appeared in the journal JAMA Network Open finds five times increased mortality risk in patients hospitalized with COVID-19, citing encephalopathy as the most common neurological disease found in the clinical setting. As more research is […]

Experienced automotive industry veteran joins IMC as new president. Dubois has served as a leader at some of the most prestigious automotive organizations in the industry. New exec looking to build team that will lead Canadian operations to surpass even most optimistic projections. DSG Global (OTCQB: DSGT) has announced that Christian Dubois, an auto executive […]

Clean Oceans campaign set to drive one of the largest ocean plastics cleanups in history. Campaign offers participants weekly prizes and one $50,000 grand prize. Powered by Lottery.com, WinTogether.org innovates the way charitable organizations raise funds and interact with donors. WinTogether.org, a charitable sweepstakes platform powered by Lottery.com, has launched the Clean Oceans campaign to […]